Research Notes

By selectively activating and inactivating a potent transcription factor in a rat's Nucleus Accumbens (NAc), a main pleasure center in the brain, scientists at the McLean Hospital in Belmont, Mass., might have found a link between cAMP response element-binding protein (CREB) and depression (A.M. Pliakas et al., "Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens," Journa

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
By selectively activating and inactivating a potent transcription factor in a rat's Nucleus Accumbens (NAc), a main pleasure center in the brain, scientists at the McLean Hospital in Belmont, Mass., might have found a link between cAMP response element-binding protein (CREB) and depression (A.M. Pliakas et al., "Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens," Journal of Neuroscience, 21[18]:7397-403, Sept. 15, 2001). Rat models with elevated expression of CREB in the NAc showed symptoms of dysphoria and despair. Directly blocking CREB activity caused the opposite effect, making the rats react as if they were treated with antidepressant drugs. Says William Carlezon, director of McLean's Behavioral Genetics laboratory: "Our data indicate that activation of CREB might be an early step in triggering depression symptoms." CREB, a transcription factor, enables activation of many genes in the brain. One effect of CREB activation is increased production of the opioid peptide dynorphin, known as the "evil cousin" of endorphin, which is responsible for "runner's high." "Like endorphin, dynorphin is also a pain killer, but it makes you feel lousy rather than good," says Carlezon. The study shows that blocking the brain's dynorphin receptors significantly decreases depression symptoms that occur with elevated levels of CREB in NAc. This link could lead to new treatments for depressions, but Carlezon emphasizes it's still early in the process. Medicinal chemists, he says, are working to efficiently deliver dynorphin blockers into the brain.

Autism Study to Use MRI on Children

The Autism Research Project at the University of North Carolina at Chapel Hill and Duke University Medical Center has begun a collaborative study designed to identify and examine the changes in brain development of young children with respect to autism. Autistic and non-autistic children between 18 and 35 months old will have their brains scanned using magnetic resonance imaging (MRI); the test will be repeated 24 months later. Funded by the National Institutes of Health, the study is designed to build on previous brain development work in autistic children. "We've seen a couple of studies where the brain in our subjects seemed to be larger than normal, says Joseph Piven, director of UNC's Neurodevelopmental Disorders Research Center. "Ages 2 through 4 are a very formative time span in brain development." The study's longitudinal approach is significant. Says Piven: "Examining this particular age group is much more powerful than if we were to scan a wider age range." This study could provide clues to the underlying reasons behind autism on the cellular level and how to study the brain more completely. "Autism is a mixed bag--there are a lot of probable causes for it," he says. "If we are able to generate a subgroup from this phenotype, we may be able to determine the genes responsible." Currently there are no brain atlases of children this age. Piven hopes to make the information from this study available to the public.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Hal Cohen

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio